Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)


NSE - NSE Delayed Price. Currency in INR
6,805.20+93.20 (+1.39%)
At close: 5:59 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open6,712.00
Prev Close6,712.00
Bid0.00 x
Ask6,805.20 x
Day's Range6,709.85 - 6,845.50
52wk Range5,178.65 - 7,121.00
1y Target EstN/A
Market Cap221.76B
P/E Ratio (ttm)52.20
BetaN/A
Volume2,506
Avg Vol (3m)6,295
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Reuters7 months ago

    P&G to challenge Indian ban on Vicks Action 500 Extra

    U.S. consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks. Procter & Gamble Hygiene and Health Care said that while it had stopped selling the product, it was evaluating all options to challenge the ban. Vicks Action 500 Extra is a fixed-dose combination of paracetamol, phenylephrine and caffeine, which was banned by India's health ministry in a notice issued over the weekend.

  • Reuters7 months ago

    P&G stops selling Vicks Action 500 Extra in India after ban

    U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk. The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by India's health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange. P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

  • We're sorry this is all we were able to find about this topic.